CN1315200A - 一种治疗腰椎间盘突出症的外用药 - Google Patents
一种治疗腰椎间盘突出症的外用药 Download PDFInfo
- Publication number
- CN1315200A CN1315200A CN 00110966 CN00110966A CN1315200A CN 1315200 A CN1315200 A CN 1315200A CN 00110966 CN00110966 CN 00110966 CN 00110966 A CN00110966 A CN 00110966A CN 1315200 A CN1315200 A CN 1315200A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- intervertebral disc
- pepper
- promote
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 208000012287 Prolapse Diseases 0.000 title 1
- 240000002234 Allium sativum Species 0.000 claims abstract description 15
- 235000004611 garlic Nutrition 0.000 claims abstract description 15
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 13
- 206010050296 Intervertebral disc protrusion Diseases 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 11
- 239000006002 Pepper Substances 0.000 claims abstract description 11
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 11
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 11
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 11
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 9
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 9
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 9
- 244000089698 Zanthoxylum simulans Species 0.000 claims abstract description 9
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940116229 borneol Drugs 0.000 claims abstract description 9
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 8
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 8
- 235000008397 ginger Nutrition 0.000 claims abstract description 8
- 241000411851 herbal medicine Species 0.000 claims abstract description 7
- 244000291564 Allium cepa Species 0.000 claims abstract description 6
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 6
- 235000020097 white wine Nutrition 0.000 claims abstract description 4
- 244000203593 Piper nigrum Species 0.000 claims abstract 3
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 240000008574 Capsicum frutescens Species 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 210000004204 blood vessel Anatomy 0.000 abstract description 7
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 abstract description 6
- 235000002568 Capsicum frutescens Nutrition 0.000 abstract description 5
- 230000028327 secretion Effects 0.000 abstract description 4
- 210000000106 sweat gland Anatomy 0.000 abstract description 4
- 230000004087 circulation Effects 0.000 abstract description 2
- 230000017525 heat dissipation Effects 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 22
- 229940079593 drug Drugs 0.000 description 16
- 230000000694 effects Effects 0.000 description 10
- 230000000144 pharmacologic effect Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 239000000341 volatile oil Substances 0.000 description 10
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 8
- 241000722363 Piper Species 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 7
- 206010006784 Burning sensation Diseases 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 235000019100 piperine Nutrition 0.000 description 5
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 5
- 229940075559 piperine Drugs 0.000 description 5
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 5
- 230000011514 reflex Effects 0.000 description 5
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000005792 Geraniol Substances 0.000 description 4
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 4
- 208000008765 Sciatica Diseases 0.000 description 4
- 235000010081 allicin Nutrition 0.000 description 4
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 4
- 244000309466 calf Species 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229940113087 geraniol Drugs 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- -1 enone Chemical compound 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (+)-Borneol Natural products C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 description 2
- FAMPSKZZVDUYOS-UHFFFAOYSA-N 2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 239000004212 Cryptoxanthin Substances 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- AKDLSISGGARWFP-UHFFFAOYSA-N Homodihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCCC(C)C)=CC=C1O AKDLSISGGARWFP-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- VQEONGKQWIFHMN-UHFFFAOYSA-N Nordihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCC(C)C)=CC=C1O VQEONGKQWIFHMN-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000124033 Salix Species 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 2
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000001390 capsicum minimum Substances 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 235000019244 cryptoxanthin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 2
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 2
- 235000002780 gingerol Nutrition 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- 229930006703 (-)-borneol Natural products 0.000 description 1
- DTGKSKDOIYIVQL-QXFUBDJGSA-N (-)-borneol Chemical compound C1C[C@]2(C)[C@H](O)C[C@H]1C2(C)C DTGKSKDOIYIVQL-QXFUBDJGSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- ILPBINAXDRFYPL-UHFFFAOYSA-N 2-octene Chemical compound CCCCCC=CC ILPBINAXDRFYPL-UHFFFAOYSA-N 0.000 description 1
- 208000035657 Abasia Diseases 0.000 description 1
- 244000151012 Allium neapolitanum Species 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 241000557833 Hua gabonii Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000000482 beta-cryptoxanthin group Chemical group 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 description 1
- 235000018889 capsanthin Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- XJQPQKLURWNAAH-UHFFFAOYSA-N dihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCC(C)C)=CC=C1O XJQPQKLURWNAAH-UHFFFAOYSA-N 0.000 description 1
- RBCYRZPENADQGZ-UHFFFAOYSA-N dihydrocapsaicin Natural products COC1=CC(COC(=O)CCCCCCC(C)C)=CC=C1O RBCYRZPENADQGZ-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- BXWQUXUDAGDUOS-UHFFFAOYSA-N gamma-humulene Natural products CC1=CCCC(C)(C)C=CC(=C)CCC1 BXWQUXUDAGDUOS-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- MLJGZARGNROKAC-VQHVLOKHSA-N homocapsaicin Chemical compound CCC(C)\C=C\CCCCC(=O)NCC1=CC=C(O)C(OC)=C1 MLJGZARGNROKAC-VQHVLOKHSA-N 0.000 description 1
- JKIHLSTUOQHAFF-UHFFFAOYSA-N homocapsaicin Natural products COC1=CC(CNC(=O)CCCCCC=CC(C)C)=CC=C1O JKIHLSTUOQHAFF-UHFFFAOYSA-N 0.000 description 1
- JZNZUOZRIWOBGG-UHFFFAOYSA-N homocapsaicin-II Natural products COC1=CC(CNC(=O)CCCCC=CCC(C)C)=CC=C1O JZNZUOZRIWOBGG-UHFFFAOYSA-N 0.000 description 1
- GOBFKCLUUUDTQE-UHFFFAOYSA-N homodihydrocapsaicin-II Natural products CCC(C)CCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 GOBFKCLUUUDTQE-UHFFFAOYSA-N 0.000 description 1
- QBNFBHXQESNSNP-UHFFFAOYSA-N humulene Natural products CC1=CC=CC(C)(C)CC=C(/C)CCC1 QBNFBHXQESNSNP-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000008127 lead poisoning Diseases 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000002219 manual therapy Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001767 medulla oblongata Anatomy 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- KWKAKUADMBZCLK-UHFFFAOYSA-N methyl heptene Natural products CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- LTHCSWBWNVGEFE-UHFFFAOYSA-N octanamide Chemical compound CCCCCCCC(N)=O LTHCSWBWNVGEFE-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000001688 paprika extract Substances 0.000 description 1
- 235000012658 paprika extract Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229960005152 pentetrazol Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000007771 sciatic neuropathy Diseases 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗腰椎间盘突出症的外用药,它是由纯中草药生姜16-20份,大蒜3-4份,尖椒1.6-2份,葱白3-4份,花椒2.5-3份,胡椒1.5-2份,薄荷3-3.5份,陈皮4-5份,冰片1.5-2份,加入白酒100-120份配制而成。本外用药可通过皮肤渗透,达到促进血管扩张,流通,促进汗腺分泌,使机体散热增加,促使血液循环,疏通经络,活血化瘀,解表散寒,使患处得到恢复,本发明是治疗腰椎间盘突出症的一种比较理想的外用药。
Description
本发明涉及的治疗腰椎间盘突出症的外用药,是纯中草药,实际为用酒浸泡的外用纯中草药剂。
现有对治疗腰椎间盘突出病的外用药甚少,疗效不显著,治愈率低。
本发明的目的旨在改进上述不足,提供一种无毒、无副作用、治愈率高的治疗腰椎间盘突出症的外用药。
为了达到上述目的,本发明是这样实现的,它是由纯中草药生姜16-20份,大蒜3-4份,尖椒1.6-2份,葱白3-4份,花椒2.5-3份,胡椒1.5-2份,薄荷3-3.5份,陈皮4-5份,冰片1.5-2份,加入白酒100-120份配制而成。
本发明的中草药根据传统医学及现代医学分析,药性及药理作用:
生姜:性辛温,归肺、脾、胃经。有发汗解表,温中止呕,化痰止咳,祛风散寒之功能。药理研究表明本品含挥发油,油中主要成份为姜醇、姜烯、水芹烯、茨烯、柠檬醛、芳香醇、甲基庚、烯酮、壬醛、d-龙脑等,尚含辣味成份姜辣素。对口腔及胃粘膜有刺激作用,能促进消化液的分泌,使食欲增加;姜有抑制肠内的异常发酵及促进气体排出的作用;对于延髓的呼吸及血管运动中枢均有兴奋作用。增进血液循环,使血压上升,促进发汗,给予呼吸物质代谢以好的影响。
大蒜:性辛温,归脾、胃、肺经。能解毒、消痈、杀虫。药理研究表明,本品大蒜鳞茎含挥发油约2%,油中主要成份为大蒜素,为一种植物杀菌素。大蒜全植株尚含大蒜氨酸蒜制菌素。大蒜体外试验对化脓性球菌、结核杆菌、痢疾杆菌、伤寒杆菌、副伤寒杆菌、霍乱弧菌及脑膜炎双球菌、多种致病性皮肤真菌均有抑制作用。口服大蒜液可使胃肠蠕动加强;腹腔注射大蒜浸液,对小白鼠支氏腹水癌有一定疗效,大蒜粗提液对大鼠腹水肉瘤细胞具有抗有丝分裂作用,饲以新鲜大蒜之小雌鼠可以完全抑制乳腺癌的发生;大蒜抑菌素对大白鼠甲醛性关节炎有抑制作用;大蒜制剂口服,可以改善慢性铅中毒症状;从大蒜提出的一种抗凝成份有降低血钙的作用。
尖椒:性辛热,归脾经,温中散寒止痛,促进血液循环。药理研究表明辣椒果实含辛辣成份,为辣椒碱、二氢辣椒碱、降二氢辣椒碱、高辣椒碱、高二氢辣椒碱,壬洗香英兰胺、辛酰香英兰胺,色素为隐黄素,辣椒红素,微量辣椒玉丝素、胡萝卜索,尚含维生素C、柠檬酸、酒石酸、苹果酸。外用作为涂擦剂,对皮肤发赤作用,使皮肤局部血管起反射性扩张,促进局部血液循环的旺盛,酊剂可用于冻疮。
葱白,性辛温,祛风散寒,作用平稳。药理研究表明含有挥发油葱蒜辣素成份,对白喉杆菌、结核杆菌、痢疾杆菌、葡萄球菌、链球菌有抑制作用,试管内对多种皮肤真菌有抑制作用,有发汗解热、利尿、健胃祛痰作用。
花椒:性辛温,归脾肾经,能温中散寒,除湿止痛、杀虫。药理研究表明花椒的果皮含挥发油,油中含异茴香醚及牻牛儿醇。花椒所含的挥发油成份牻牛儿醇小量对家兔离体肠管呈持续性的蠕动加强大量则使之抑制;大白鼠口服牻牛儿醇,小量有轻度利尿,大量则显著抑制尿;牻牛儿醇给家兔静脉注射引起血压迅速深降、反射性地引起呼吸兴奋。外用涂擦在皮肤上能祛除病邪,疏通关节血脉。
胡椒:性辛热,人胃,大肠经。能温中散寒,下气、消痰。药理研究表明,胡椒主含胡椒碱,胡椒脂碱及挥发油等。胡椒内服有驱风健胃作用;胡椒碱有明显对抗戊四唑惊厥的作用及对抗电惊厥的作用;根据胡椒碱对自发活动的影响和对硫妥纳的协同作用,可看它有明显的镇静作用;胡椒碱尚有微弱的抗疟作用。外用涂擦皮肤可起到温中解毒解瘀。
薄荷:性味归经,辛,凉,归肺、肝经。本品辛以发散,凉以清热,清轻凉散,为疏散风热常用之品。药理研究表明薄荷含挥发油,油中主要成份为薄荷醇及薄荷酮、薄荷脂、茨烯、柠檬烯、
烯等,薄荷油内服有发汗,解热及兴奋中枢作用;对离体肠管有解痉作用,薄荷煎剂对人型结核菌、伤寒杆菌有抑制作用,薄荷制剂局部应用时,可使皮肤粘膜的冷觉受畎产生冷觉反射,引起皮肤粘膜血管收缩,薄荷油对皮肤有刺激作用,并可慢慢透入皮肤,因此引起长时间的充血,同时也反射地引起深部组织的血管变化调整血管的功能而达到治疗作用。
陈皮:性辛、苦、温,归脾、肺经,能理气健脾,燥湿化痰。药理研究表明:橘皮含挥发油(其中主要为柠檬烯)、黄酮甙(橙皮甙、胡萝卜素、隐黄素、维生索C及B等).橘皮挥发油对消化道有缓和的刺激作用,有利于胃肠积气的排出,能促进胃液分泌,有助于消化;橘皮煎剂及醇提取液对于离体和体蛙心均有兴奋作用,剂量过大反而有抑制现象出现,给蟾蜍全身血管灌流时发现有血管收缩流率减缓的现象;静脉注射于狗及兔,可见血压迅速上升,经反复用药亦无耐受产生。外用涂擦皮肤可起到诸药均有通透皮肤粘膜进入血液达到促进血液循环,活血化瘀,止痛消炎,伸筋止痛之目的。
冰片,性辛,苦,微寒。归心、脾、肺经。能开窍醒神,清热止痛。药理研究表明:冰片为龙脑香的树脂和挥发油中取得的结晶。为多种萜类成份,主要为右旋龙脑,又含少量桉树脂、左旋龙脑、葎草烯等。冰片应用于局部对感觉神经的刺激很轻,而有某些止痛及温和的防腐作用;体外试验对金黄色葡萄球菌、大肠杆菌、猪霍乱菌及羊毛样小孢子菌、红色毛癣菌有抑制作用。
白酒:局部涂擦于皮肤,可加速热的挥发,故有冷感,可用于高热病人,高浓度乙醇能使细胞原浆脱水,并发生沉淀,故有收敛及刺激作用。
本发明属纯中草药加酒配制而成,是一种外用药,涂在患处,可通过皮肤渗透,达到促进血管扩张、流通,促进汗腺分泌,使机体散热增加,增加血液循环,疏通经络,活血化瘀,解表散寒,使患处得到恢复,本发明外用无毒、无副作用,是治疗腰椎间盘突出症的一种比较理想的外用药。
为了更好地理解与实施,下面以实施例进一步说明如下:
例1,取生姜16千克,大蒜3千克,尖椒1.6千克,葱白3千克,花椒2.5千克,胡椒1.5千克,薄荷3千克,陈皮4千克,冰片1.5千克,加入100千克45度白酒,常温下在反应罐里浸泡200小时后,用120目筛网过滤,然后灌瓶封装,每100g一瓶即可。
例2,取生姜18千克,大蒜3.5千克,尖椒1.8千克,葱白3.5千克,花椒2.8千克,胡椒1.8千克,薄荷3.2千克,陈皮4.5千克,冰片1.8千克,加入110千克45度白酒,在不锈钢锅内煎制,开始温火,开锅后再用慢火煎煮15分钟后用120目筛网过滤静置,然后灌瓶封装,每100g一瓶即可。
例3,取生姜20千克,大蒜4千克,尖椒2千克,葱白4千克,花椒3千克,胡椒2千克,薄荷3.5千克,陈皮5千克,冰片2千克,加入120千克45度白酒,在不锈钢锅内煎制,开始温火,开锅后再慢火煎煮15分钟后用120目筛网过滤静置,然后灌瓶封装,每50g一瓶即可。
调整腰椎、治疗腰椎间盘突出症,少数患者症状使用该药物和正骨可立即完全缓解,大多数患者在治疗当中明显减轻,需要一个疗程,7-8天基本症状完全消失治愈,本药物治疗疗效可靠,无副作用,渗透力强,直达病灶,用药时,从大椎开始整个后背到坐骨先涂点药液打底,保护皮肤,开始正骨手法穴位推拿理顺,15分钟后,汗腺孔张开,进行上下涂该药,包括腿上穴位用药,用药量50-60g,24小时一次,从治疗前后CT检查对照看:治疗后突出的椎间盘基本上复位,治疗一年多的患者至今没有复发。在临床上的症状可完全消失。其机理椎体及其附件椎间是一个整体,当腰椎间盘突出后破坏了原相关椎间力的平衡,从而导致关节突的相对位置的改变,表现为后关节的紊乱,以CT检查结果、结合临床触摸检查作为施术依据,通过正骨手法穴位推拿配合药物,调整患椎椎位而使错动的关节突,关节面对位,两椎体相对的位置复原,同时使髓核部分全部还纳,恢复了腰椎的生理和生物学状态,解除了对脊髓及神经根的压迫与刺激,故临床症状完全可消失。经临床300余病例观察,每天涂擦患处一次,每次使用50-60g,其中有效291例,占97%,显效275例,占91.66%,近愈7例,占2.33%,远愈9例,占3%,无效9例,占3%。
典型病例:
病例1:
姓名:李××,性别:女,年龄:49岁
籍贯:山东蓬莱,民族:汉,职业:工人
就诊时间:99年1月16日
主诉:后背发板,不能直立行走,疼痛难忍,已住了4天医院没有好转。
诊断:风寒湿热型号,受寒而引起,有两个压痛点,头部非常沉重,面部黄纸色(西医称肌纤维炎)
用药:本发明制成的外用剂每次50g
治疗:开始手法治疗,把汗腺孔理顺开,涂药以身体燥热,直达病灶,反射起来后背像火烧一样,反射1小时,患者说非常轻松,不过出现了象鞭子抽的紫血柳抽,24小时后二次涂药火烧感觉为30分钟反射,紫血柳抽消失,也不痛了,24小时后三次涂药反射时间也短了,疼痛症状基本消失,连续又三次涂药巩固恢复,现已痊愈。通过CT检查症状全无。
病例2:
姓名:刘××,性别:男,年龄:56岁
籍贯:山东长岛,民族:汉,职业:干部
就诊时间:98年6月25日
主诉:38岁患病,去过很多医院求医,97年在济南军区总医院,腰椎间盘突出,做过手术,现病情复发,腰部不能活动,疼痛非常厉害。
诊断:急性炎症,手术伤口L4、L5为压痛点。
用药:本发明制成的外用剂每次50g
治疗:通过运用中医正骨手法穴位推拿理顺配合药物治疗发挥作用,上午11点涂药治疗,有火热感,当天下午非常轻松,晚上有反映症状加剧痛,痛了一夜,第二天上午疼痛很快消失,24小时后涂药治疗,火热感觉也轻了,也不痛了,24小时后第三次涂药一切症状消失,连续巩固涂药3次,至今无复发。CT检查正常。
病例3:
姓名:宋××,性别:男,年龄:38岁
籍贯:山东长岛,民族:汉,职业:船员
就诊时间:98年12月16日
主诉:87年患病,在威海、青岛、烟台诊断腰椎间盘脱出,坐骨神经痛(有外伤史),用牵引治疗,病没有好转,多年来吃药维护,现病情加重,在海上作业,在船上卧床一星期,不能活动。
诊断:受寒引起,湿热型号,L4、L5、S1腰椎间盘突出,坐骨神经痛,压迫大腿到小腿,疼痛厉害。
用药:本发明制成的外用剂每次50g
治疗:运用中医正骨手法穴位推拿,开始一次药物涂擦,涂药以后在胸椎间中部出现了黑血块,有拇指头大小,晚上有加剧痛反映,小腿肚肿胀,小腿部有一片受寒白霜,火烧感觉达30分钟,24小时后二次涂药治疗,火烧感觉15分钟,疼痛也轻了,黑血块也很快消失,小腿肚肿胀也消失,24小时后三次涂药治疗,全身检查腰椎间盘疼痛消失,症状基本消失,连续巩固4次,恢复正常机能,现已痊愈。CT检查正常。
病例4:
姓名:范××,性别:男,年龄:54岁
籍贯:山东长岛,民族:汉,职业:林场工人
就诊时间:99年2月8日
主诉:98年6月份患病,下肢右腿痛,在连城部队军医诊断:坐骨神经痛,吃了几种药,下银针,拔头罐,没有好转,9月初病情加重,卧床不起,右腿瘫痪5个月。
诊断:湿热型,大腿根一处压痛点(承扶穴位),二处在委中穴位压痛点,三处在承山穴位为压点,为风湿变形,受寒侵袭太大。
用药:本发明制成的外用剂每次50g
治疗:通过穴位推拿理顺配合药物,第一次涂药以后,在承扶穴位有跳动感,其他两穴位没有反映,10分钟以后感觉上下火烧,并能站立,火烧感觉长达8个小时,晚上反映有加剧痛感,第二天减轻,24小时后第二次涂药火烧感觉达2小时,疼痛逐渐轻,24小时后第三次涂药症状消失,下地到院子开始活动散步,并继续涂药4次巩固,现已痊愈。
病例5:
姓名:王××,性别:女,年龄:49岁
籍贯:山东长岛,民族:汉,职业:家庭妇女
就诊时间:99年1月5日
主诉:95年患病,因外伤引起,病倒2个月找人伺候,外出多次花费1万余元,病情不见好转。
诊断:湿热型号,坐骨神经炎,腰椎间盘突出,压迫到大腿根底。
用药:本发明制成的外用剂每次50g
治疗:通过正骨法穴位推拿,一次涂药,有紫血块出现,火烧感觉,晚上有加剧痛的反映,24小时后第二次涂药,火烧感觉轻了,紫血块没有消失,24小时后第三次涂药,紫血块不见了,火烧感觉短,疼痛消失,可以爬起来下地活动,接连又三次巩固涂药,现在恢复正常机能痊愈。
Claims (1)
1、一种治疗腰椎间盘突出症的外用药,其特征是它是由纯中草药生姜16-20份,大蒜3-4份,尖椒1.6-2份,葱白3-4份,花椒2.5-3份,胡椒1.5-2份,薄荷3-3.5份,陈皮4-5份,冰片1.5-2份,加入白酒100-120份配制而成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00110966 CN1111420C (zh) | 2000-03-31 | 2000-03-31 | 一种治疗腰椎间盘突出症的外用药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00110966 CN1111420C (zh) | 2000-03-31 | 2000-03-31 | 一种治疗腰椎间盘突出症的外用药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1315200A true CN1315200A (zh) | 2001-10-03 |
CN1111420C CN1111420C (zh) | 2003-06-18 |
Family
ID=4580917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 00110966 Expired - Fee Related CN1111420C (zh) | 2000-03-31 | 2000-03-31 | 一种治疗腰椎间盘突出症的外用药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1111420C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104498275A (zh) * | 2014-12-09 | 2015-04-08 | 叶书平 | 一种番木瓜保健药酒 |
CN105343442A (zh) * | 2015-12-15 | 2016-02-24 | 孔繁明 | 一种治疗腰椎间盘突出症的外用药及其制备方法 |
CN109045251A (zh) * | 2018-07-30 | 2018-12-21 | 马南行 | 一种外用改善微循环的组合物及其应用 |
CN110279746A (zh) * | 2019-07-16 | 2019-09-27 | 揭阳市独角金枪草本植物股份有限公司 | 一种治疗跌打损伤的按摩膏及其制备方法 |
-
2000
- 2000-03-31 CN CN 00110966 patent/CN1111420C/zh not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104498275A (zh) * | 2014-12-09 | 2015-04-08 | 叶书平 | 一种番木瓜保健药酒 |
CN105343442A (zh) * | 2015-12-15 | 2016-02-24 | 孔繁明 | 一种治疗腰椎间盘突出症的外用药及其制备方法 |
CN109045251A (zh) * | 2018-07-30 | 2018-12-21 | 马南行 | 一种外用改善微循环的组合物及其应用 |
CN110279746A (zh) * | 2019-07-16 | 2019-09-27 | 揭阳市独角金枪草本植物股份有限公司 | 一种治疗跌打损伤的按摩膏及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1111420C (zh) | 2003-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101391077B (zh) | 一种治疗慢性盆腔炎的中药制备方法 | |
CN104013835A (zh) | 一种治疗高血压的中药 | |
CN101905011A (zh) | 一种用于治疗颈椎病的中药组合物 | |
CN104258278A (zh) | 骨伤灵喷雾剂 | |
CN1111420C (zh) | 一种治疗腰椎间盘突出症的外用药 | |
CN102078586A (zh) | 一种治疗颈椎病的药剂 | |
CN109700856A (zh) | 一种具有活血通络、舒筋止痛的中药外用方剂 | |
CN110075258A (zh) | 一种糖尿病足溃疡外用药 | |
CN104825956A (zh) | 防治中风、康复筋骨关节的药 | |
CN107551004A (zh) | 一种治疗颈椎病的外敷中药蜡灸 | |
CN106924581A (zh) | 一种治疗腹痛的药酒及其制备方法 | |
CN101797371B (zh) | 一种用于减肥按摩的药物组合物 | |
CN100998660B (zh) | 治疗椎动脉型颈椎病中药贴及其制备方法 | |
CN105267876A (zh) | 一种治疗胃石症的药物 | |
CN109157569A (zh) | 一种温痛舒涂膜剂及制备方法 | |
CN114732882B (zh) | 一种中药组合物及其制备方法和应用 | |
CN108420856A (zh) | 治疗骨关节、筋络疼痛的中药制剂 | |
CN103933476B (zh) | 一种治疗肋间神经痛的药物组合物及其制备方法和用途 | |
CN102614350A (zh) | 一种治疗颈椎病的中药 | |
CN102028876B (zh) | 一种治疗骨质增生的中药液 | |
CN105943639A (zh) | 一种辅助治疗慢性硬脑膜下血肿的中药组合物 | |
CN105596783A (zh) | 外敷用中药膏贴及其制备方法 | |
CN110772624A (zh) | 一种通经活络的瑶药足浴提取浓缩液的制备方法 | |
CN114404491A (zh) | 一种治疗骨质疏松患者焦虑抑郁的涂擦剂及其制备方法 | |
CN104689176B (zh) | 一种治疗膝骨关节炎的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1067235 Country of ref document: HK |